Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Global, regional and national burden of drug use disorders, 1990–2021

Decomposition analysis, health inequality analysis and predictions to 2035

Bibliographic Data

ID22074712
AuthorsRui Jin (0000-0003-4544-6535, Hangzhou Normal University), Ruiying Jin, Shenyu Zhang (0009-0004-2338-4016, Hangzhou Normal University), Jun Xiong (0000-0002-2320-0780, Hangzhou Normal University, corresponding author), Baixi Liu (Hangzhou Normal University)
Year2025
Volume13
Pages1588607-1588607
Publication date2025-10-21
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2025.1588607
PMID41194996
OpenAlexW4415373285
LanguageEN
Citations received2
References cited38

Background: Drug use disorders (DUDs), a significant public health issue worldwide, encompass disorders related to sedatives, cannabis, opioids, heroin, hallucinogens, club drugs, and inhalants. This study examines the changes in the global burden of DUDs from 1990 to 2021, aiming to provide a scientific foundation for strategies to mitigate the harms associated with substance abuse. Methods: The study utilized Global Burden of Disease (GBD) 2021 data to analyze trends in the incidence, prevalence, mortality, disability-adjusted life years (DALYs) associated with DUDs through Socio-demographic Index (SDI), attributable risk factors, and EAPC. Decomposition analysis was employed to assess the impact of age, gender, and SDI on the burden of DUDs, while the inequality distribution of DALYs was examined using the inequality slope index (SII) and the concentration index (CI). Results: Opioid use disorder accounted for the highest age-standardized disability rates (ASDR) and age-standardized mortality rates (ASMR) among the five drug use disorders, while cannabis use disorder is the leading cause of Age-standardized prevalence rates (ASPR). The Age-standardized incidence rates (ASIR) of opioid use disorder has demonstrated a downward trend, whereas both ASPR and ASMR have shown an increase; notably, the ASIR for opioid use disorder has declined the least among the five drug use disorders. The burden of DUDs in high SDI areas is significantly greater than that in low SDI areas, with income inequality exacerbating the uneven distribution of DALYs. The primary attributable risk factors are drug use and behavioral risks. While the ASIR of opioid use disorder is increasing, while others are experiencing a decline. The burden of DUDs varies among the five drug use disorders due to factors such as population aging, population changes, and age distribution. Conclusion: The findings reveal absolute and relative inequalities in DALYs associated with drug use disorders, which are concentrated in high-income regions

Decomposition · Drug · Health equity · Inequality · MEDLINE · Trend analysis · HIV, Drug Use, Sexual Risk · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes

  • Global burden and forecast of infectious diseases attributable to drug use

    Open Access•Xueqing Gong, Xue‐Qing Gong et al.•Frontiers in Public Health•2025

  • Global substance use disorders burden from 1990 to 2021

    Open Access•Tianyue Yu, Meiti Wang et al.•Journal of Global Health•2026

  • The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016

    Open Access•Louisa Degenhardt, Fiona J Charlson et al.•The Lancet Psychiatry•2018

  • Epidemiology of DSM-5 Drug Use Disorder

    Bridget F Grant, Tulshi D Saha et al.•JAMA Psychiatry•2016

  • Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021

    Open Access•Mohsen Naghavi, Kanyin Liane Ong et al.•The Lancet•2024

  • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (Dalys), and healthy life expectancy (Hale) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021

    Open Access•Alize J Ferrari, Damian Francesco Santomauro et al.•The Lancet•2024

  • Sex and gender differences in substance use disorders

    Open Access•R Kathryn McHugh, Victoria R Votaw et al.•Clinical Psychology Review•2018

  • Prevention, early intervention, harm reduction, and treatment of substance use in young people

    Open Access•Emily Stockings, Wendy Hall et al.•The Lancet Psychiatry•2016

  • Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050

    Open Access•Kanyin Liane Ong, Lauryn K Stafford et al.•The Lancet•2023

  • Mental Health, Substance Use, and Suicidal Ideation During the Covid-19 Pandemic — United States, June 24–30, 2020

    Open Access•Mark É Czeisler, Rashon I Lane et al.•MMWR. Surveillance Summaries•2020

  • Global burden of drug use disorders by region and country, 1990–2021

    Open Access•Shuyan Zhang, Xiaoying Qi et al.•Frontiers in Public Health•2024

  • Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035

    Open Access•Tongchao Zhang, Lin Sun et al.•BMC Public Health•2024

Citations per year2
Citation span2025 - 2026 (2)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae